Catalent increases sterile fill/finish manufacturing capacity

Published: 6-Jun-2012
Packaging

Construction of newly renovated facility in North Carolina now complete


Catalent Pharma Solutions has now completed the construction of its newly renovated 3,300ft2 aseptic fill/finish manufacturing facility at Research Triangle Park (RTP), North Carolina, US.

Catalent has a comprehensive sterile product formulation and development offering at its RTP site, where the product development group conducts preformulation, formulation development, process development and manufacturing support in addition to offering full service analytical development and stability capabilities.

The state-of-the-art sterile clinical manufacturing suite will provide Class A manufacturing space containing a flexible aseptic vial filling line capable of producing Phase I and Phase II clinical trial materials. These fill/finish facilities are designed to comply with global GMP requirements.

The renovation increase four-fold the sterile fill-finish capacity at the Catalent RTP site and adds a new complementary technology to Catalent’s existing service offerings. ‘It is part of Catalent’s ongoing investment to provide integrated solutions to meet biologic and biosimilar drug development companies’ growing needs,’ said Christine Dolan, vice president and general manager of Catalent’s Development and Analytical Solutions business.

‘Combined with Catalent’s GPEx technology, expert biopharmaceutical lab services capabilities, world leading clinical trial supply services and commercial manufacturing capabilities, we will be able to help our customers bring more products from gene to market.’

  • Companies:
  • Catalent
See more

You may also like

Packaging

Catalent Biologics completes $14m medicine packaging expansion

Read more
US-based Catalent has completed a 15,000 sqft expansion at its Bloomington, Indiana facility

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Avoiding glass delamination Contamination with glass flakes caused by delamination of the internal finish of container closure systems or prefilled syringes has caused numerous drug recalls. Surface imperfections and aggressive drug components can lead to interaction between product and container, resulting in leaching, dissolution, ion exchange and formation of precipitants or particles; use of cyclic olefin polymers as an alternative to glass can avoid these issues
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Particulates in parenterals Particulate matter is a key indicator of quality for injectable drug products. Test methods are being improved with the intent to find the materials responsible for the particle(s). The desired goal of zero defects is not a workable acceptance criterion for visible particulate matter because of current packaging components and processing capabilities. The value of vision inspection systems for elastomeric primary components is shown to mitigate the risk of particulates in finished parenteral drug products.
  3. AMC and filtration Bill Anderson of McLeod Russel reports on the eradication of AMC with AFP carbon filters
  4. Sealed Air launches multi-layer film for multi-chamber medical packs Sealed Air Medical Applications, the supplier of protective medical and pharmaceutical packaging and thermoformed products, has introduced Nexcel M331, a multilayer film specially designed for multi-chamber applications where a frangible seal is needed to allow the components to mix before being administered.
  5. Selection criteria for medical device packaging Packaging design is often last on the ‘to do’ list of medical device manufacturers, despite complex regulatory requirements. Industry experts at a recent Medical Device Packaging seminar gave many good reasons why companies should think about it earlier

Upcoming event

Clinical Pharmacy Congress

10-11 May 2024 | Conference | London, UK See all

You may also like

Packaging

Catalent Biologics completes $14m medicine packaging expansion

US-based Catalent has completed a 15,000 sqft expansion at its Bloomington, Indiana facility
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Employing QbD to mitigate risk in aseptic parenteral fill and finish

Blow/fill/seal technology, used widely for ophthalmic, respiratory and parenterals, has been slow to make an impact in the US injectables market. Bill Hartzel, Director, Strategic Execution, Advanced Delivery Technologies, Catalent Pharma Solutions, reviews how its potential advantages meet QbD principles and mitigate the risk in parenteral filling applications
You need to be a subscriber to read this article.
Click here to find out more.
Design & Build

Planning a facility upgrade without service interruptions

Catalent decided to undertake a fundamental redesign and improvement in the layout of its facility in Schorndorf to meet the latest standards, including a radical change to the air handling systems. The major project was planned and implemented with minimal disruption to the site\'s customer base
Packaging

Catalent purchases 10-colour KBA press to support its European printed components business

Catalent Pharma Solutions, a US provider of technology and services to the global pharmaceutical, biotechnology and consumer health industry, has bought a 10-colour KBA Rapida 106 printing press for its printed components facility in Dublin, Ireland. Due to be installed next month, the press is capable of printing 15,000 sheets per hour. It is fitted with KBA’s QualiTronic full-sheet scanning system, which was developed for the German manufacturer’s currency printing presses.
Design & Build

Amkor Technology announces cleanroom facility plans in Vietnam

The semiconductor packaging and test services provider has made plans to expand capacity with new factory in Bac Ninh
Containment

ATS continues acquisition spree with pharma packaging addition

After the recent acquisition of aseptic specialist Comecer, ATS has added a specialised manufacturer of pharmaceutical processing and packaging equipment and systems DF
Packaging

Clearing up the bioplastic confusion

In clean and sterile environments there is a need for a lot of single-use consumables that contain plastic, but this poses an obvious environmental challenge. The categories of ‘green’ plastics can be confusing, but Bill Gaule from Key Plastics says clarifying the terminology of these bioplastics is vital to their increased use in industry
Subscribe now